IRIS - Res&Arch Institutional Research Information System - Research & Archive

BIAGIOLI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.372
AS - Asia 2.623
EU - Europa 2.005
SA - Sud America 390
AF - Africa 66
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.466
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.267
SG - Singapore 1.203
IT - Italia 558
CN - Cina 437
IE - Irlanda 356
RU - Federazione Russa 310
HK - Hong Kong 309
BR - Brasile 284
VN - Vietnam 273
FR - Francia 149
DE - Germania 142
FI - Finlandia 87
GB - Regno Unito 85
KR - Corea 70
SE - Svezia 56
CA - Canada 55
IN - India 53
UA - Ucraina 47
PL - Polonia 46
AT - Austria 38
IQ - Iraq 38
TR - Turchia 37
AR - Argentina 36
BD - Bangladesh 34
NL - Olanda 31
MX - Messico 30
ZA - Sudafrica 28
JP - Giappone 27
PK - Pakistan 21
ES - Italia 20
ID - Indonesia 20
BE - Belgio 19
SA - Arabia Saudita 19
EC - Ecuador 17
CH - Svizzera 15
CO - Colombia 13
VE - Venezuela 13
UZ - Uzbekistan 12
UY - Uruguay 11
MA - Marocco 9
LB - Libano 8
IL - Israele 6
LT - Lituania 6
MY - Malesia 6
PH - Filippine 6
PY - Paraguay 6
AU - Australia 5
NP - Nepal 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
GR - Grecia 4
TN - Tunisia 4
CL - Cile 3
DK - Danimarca 3
DZ - Algeria 3
EG - Egitto 3
IR - Iran 3
JO - Giordania 3
KE - Kenya 3
KW - Kuwait 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BZ - Belize 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GP - Guadalupe 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MD - Moldavia 2
MK - Macedonia 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
Totale 8.451
Salva come PNG Salva come JPEG
Città #
Singapore 922
Chandler 501
Dublin 351
San Jose 325
Hong Kong 308
Ashburn 288
Perugia 240
San Mateo 196
Santa Clara 130
Moscow 118
Boardman 113
Beijing 96
Dong Ket 96
Lauterbourg 93
Ann Arbor 85
Medford 76
Princeton 75
Los Angeles 73
Seoul 68
Altamura 63
Munich 60
Ho Chi Minh City 54
Lawrence 52
Wilmington 51
New York 50
Hanoi 49
Warsaw 42
Dearborn 41
São Paulo 41
Andover 37
Orem 29
Brooklyn 28
Helsinki 28
Turku 27
Dallas 26
Tokyo 26
Piscataway 25
Houston 23
Redmond 23
Montreal 20
Vienna 20
Council Bluffs 19
Brussels 18
Chicago 18
Johannesburg 18
Redwood City 18
Baghdad 16
Hefei 16
Norwalk 16
Nuremberg 16
Saint Petersburg 16
Stockholm 16
The Dalles 16
Amsterdam 15
Denver 15
Frankfurt am Main 15
Bologna 14
Chennai 14
London 14
Rome 14
Atlanta 13
Poplar 13
Toronto 13
Florence 12
Milan 12
Mexico City 11
Shanghai 11
San Francisco 10
Ankara 9
Columbus 9
Seattle 9
Vicenza 9
Den Haag 8
Des Moines 8
Lahore 8
Lappeenranta 8
Naples 8
Riyadh 8
Cambridge 7
Guayaquil 7
Manchester 7
New Delhi 7
Phoenix 7
Querétaro 7
Quito 7
Buffalo 6
Curitiba 6
Izmir 6
Jacksonville 6
Jeddah 6
Karachi 6
San Diego 6
San Paolo di Civitate 6
Woodbridge 6
Boston 5
Brasília 5
Buenos Aires 5
Can Tho 5
Charlotte 5
Da Nang 5
Totale 5.585
Salva come PNG Salva come JPEG
Nome #
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 139
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential 131
Wnt/beta-Catenin Signaling Induces Integrin alpha 4 beta 1 in T Cells and Promotes a Progressive Neuroinflammatory Disease in Mice 126
Glucocorticoid and B cell development: role of Glucocorticoid-induced leucine zipper 124
Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment 124
LACK OF GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (GILZ) RESULTS IN B CELL LYMPHOPROLIFERATIVE DISORDER IN MICE 121
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 120
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 116
GILZ promotes production of peripherally induced Treg cells and mediates the crosstalk between glucocorticoids and TGF-β signaling 115
GILZ REGULATES PRODUCTION OF PTREG AND TTREG CELLS AND IS NECESSARY FOR GLUCOCORTICOID-MEDIATED INDUCTION OF TREG CELLS 114
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 112
Lack of glucocorticoid-induced leucine zipper (GILZ) deregulates B-cell survival and results in B-cell lymphocytosis in mice 110
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 109
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 109
241 - GPBAR1 (TGR5) is a Modulator of Liver Immunity and Reverses Liver Inflammation in a Mouse Models of Acute Hepatitis 106
Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders 106
Glucocorticoid indeced lLeucine Zipper protein (GILZ) regulates Hematopoietic stem cell engrafment and myeloid differentiation in a mouse model of CEBPA mutant acute myeloid leukemia 105
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 104
Glucocorticoid-induced leucine Zipper (GILZ) controls T lymphocytes differentation 103
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 103
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 103
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 101
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 101
Long- Glucocrticoid induced Leucine Zipper interacts with Ras pathway and is essential for spermatogenesis 100
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 100
GILZ regulates the development of Treg cells via regulation of crosstalk between Glucocorticoids and TGF-beta 99
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 99
Bile Acid Signaling in Inflammatory Bowel Diseases 99
Analysis of Oral and Gut Microbiota Composition in Children with Dental Caries by NGS Approaches 98
Glucocorticoid-induced leucine Zipper (GILZ) anf the new isoform L-GILZ mediates the anti-inflammatory effects of glucocorticoids 98
Role of GILZ in mediating the anti-inflammatory actions of glucocorticoids 96
Bile Acids Activated Receptors Regulate innate immunity 95
Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH 95
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 95
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 94
Disruption of TFG beta-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand 93
Bile Acids Activated Receptors in Inflammatory Bowel Disease 92
Long-glucocorticoid-induced leucine zipper (L-GILZ) expression as a new diagnostic biomarker for male infertility associated with exposure to electromagnetic fields and radiofrequency radiation. 91
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 91
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 91
Metabolic variability of a multispecies probiotic preparation impacts on the anti-inflammatory activity 88
Tu1546 – Gpbar1 is a Modulator of Liver Immunity and Its Agonism Reverses Acetaminophen-Induced Hepatotoxicity by Modulating Recruitment of Liver Macrophages 88
Glucocorticoid-induced leucine zipper (GILZ) is involved in Th2-mediated oxazolone-induced colitis 86
Sa1518 – Mechanism of Acute Liver Decompensation Caused by Obeticholic Acid in Cholestasis is Fxr Dependent 86
Mo2014 – Comparative Effects of Bar502, a Dual Fxr and Gpbar1 Agonist, Obeticholic Acid and Ursodeoxycholic Acid in a Rodent Model of Nash 86
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 85
Divergent effectiveness of multispecies probiotic preparations on intestinal microbiota structure depends on metabolic properties 85
Bile acids and their receptors in metabolic disorders 85
GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis 85
The effect of Ara-C treatment on hematopoietic stem cell expasion and leukemogenesis in a mouse model of CEBPA mutant acute myeloid leukemia 84
Recombinant long-Glucocorticoid-induced leucine zipper (L-GILZ) protein restores the control of proliferation in gilz KO spermatogonia 84
Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice 84
Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury 84
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis 84
Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH) 84
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 83
Glucocorticoid-induced leucine zipper (GILZ) is a regulator of intestina immune homeostatsis and anti-inflammatory effects of glucocorticoids 83
Combinatorial targeting of GPBAR1 and CYSLTR1 reveals a mechanistic role for bile acids and leukotrienes in drug induced liver injury 82
Su1053 - Bar704, a Potent and Selective Fxr Agonist Protects Against Intestinal Fibrosis 81
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 79
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 79
REGULATION OF HEMATOPOIETIC STEM CELL (HSC) DEVELOPMENT: ROLE OF GLUCOCORTICOID INDUCED LEUCINE ZIPPER (GILZ) 79
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 78
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 77
VARIABILITY IN INDUSTRIAL PRODUCTION AFFECTS PROBIOTICS ACTIVITY: IDENTIFICATION OF BATCHES OF PROBIOTIC VSL#3 THAT INCREASES INTESTINAL PERMEABILITY AND WORSENS COLITIS IN RODENTS 77
Tu1738 - The Aryl Hydrocarbon Receptor Mediates Anti-Inflammatory Activities of Natural and Synthetic Pelargonidines in Mouse Models of Colitis 75
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease 75
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 74
Bile acids and bile acid activated receptors in the treatment of Covid-19 74
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation 74
Allo-lithocholic acid, a microbiome derived secondary bile acid, attenuates liver fibrosis 73
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 72
GPBAR1 (TGR5) LIGATION PROTECTS AGAINST COLITIS DEVELOPMENT BY REGULATING LEUKOCYTE TRAFFINKING AND PROMOTING A IL-10 DEPENDENT SHIFT IN THE M1/M2 PHENOTYPE 71
The identification of farnesoid X receptor modulators as treatment options for non-alcoholic fatty liver disease 71
Structural Basis for Developing Multitarget Compounds Acting on Cysteinyl Leukotriene Receptor 1 and G-Protein-Coupled Bile Acid Receptor 1 71
Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity 68
Immunomodulatory functions of FXR 68
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders 67
Glucocorticoid-Induced Leucine Zipper (GILZ) controls inflammation and tissue damage after spinal cord injury. 67
Special FX: Harnessing the Farnesoid-X-Receptor to Control Bile Acid Synthesis 67
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 66
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain 66
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 66
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4−/− Mice 65
Discovery of Bile Acid Derivatives as Potent ACE2 Activators by Virtual Screening and Essential Dynamics 63
GPBAR1 (TGR5) AGONISM REVERSES ENDOTHELIAL DYSFUNCTION AND LIVER INJURY IN A DIETETIC MODEL OF STEATOHEPATITIS 62
Tu1748 - Probiotics Beyond Taxonomy: Evidence that Anti-inflammatory Properties of Live Biotherapeutic Products Require Phenotypic Characterization 62
Bile acids and their receptors in hepatic immunity 61
Sa1931 – Physico-Chemistry, Proteomics and In Vivo Comparative Tests to Reveal Variability in Multistrain Probiotic Formulations 60
Immunology of bile acids regulated receptors 59
Future trends in the treatment of non-alcoholic steatohepatitis 57
Phenotyping the Chemical Communications of the Intestinal Microbiota and the Host: Secondary Bile Acids as Postbiotics 56
Organoids as ex vivo culture system to investigate infection-host interaction in gastric pre-carcinogenesis 54
Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments 53
Navigation in bile acid chemical space: Discovery of novel FXR and GPBAR1 ligands 52
BAR502/fibrate conjugates: synthesis, biological evaluation and metabolic profile 51
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 50
Modeling Inflammatory Bowel Disease by Intestinal Organoids 47
Immunephenotype Predicts Response to Vedolizumab: Integrating Clinical and Biochemical Biomarkers in the Treatment of Inflammatory Bowel Diseases 46
Expanding the Library of 1,2,4-Oxadiazole Derivatives: Discovery of New Farnesoid X Receptor (FXR) Antagonists/Pregnane X Receptor (PXR) Agonists 44
Totale 8.511
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.507
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.507
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021149 0 0 0 0 0 0 0 0 0 26 17 106
2021/2022673 13 143 7 16 14 6 38 175 15 69 88 89
2022/20231.378 90 242 14 124 132 123 2 82 495 3 55 16
2023/2024563 31 48 20 17 22 3 141 31 31 20 122 77
2024/20251.628 21 139 87 77 151 126 116 131 315 78 268 119
2025/20263.621 238 248 189 556 578 325 570 180 398 339 0 0
Totale 8.750